RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression

Cell Reports

Volumn 3, Issue 6, 2013, Pages 2059-2074

  Martínez, Paula ^a   Gómez López, Gonzalo ^a   García, Fernando ^a   Mercken, Evi ^b   Mitchell, Sarah ^b   Flores, Juana M ^c   deCabo, Rafael ^b   Blasco, Maria A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RAP1 PROTEIN;

ABDOMINAL FAT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FATTY ACID METABOLISM; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID STORAGE; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; PGC1 ALPHA GENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TELOMERE HOMEOSTASIS; TRANSCRIPTION REGULATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; FEMALE; GENE EXPRESSION; HUMANS; INTRA-ABDOMINAL FAT; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OBESITY; RAP1 GTP-BINDING PROTEINS; TELOMERE-BINDING PROTEINS; TRANSFECTION;

MUS;

EID: 84879750757     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.05.030     Document Type: Article

References (62)

1. Akiyama T.E., Nicol C.J., Fievet C., Staels B., Ward J.M., Auwerx J., Lee S.S., Gonzalez F.J., Peters J.M. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J.Biol. Chem. 2001, 276:39088-39093.
2. Blasco M.A. The epigenetic regulation of mammalian telomeres. Nat. Rev. Genet. 2007, 8:299-309.
3. Buchman A.R., Kimmerly W.J., Rine J., Kornberg R.D. Two DNA-binding factors recognize specific sequences at silencers, upstream activating sequences, autonomously replicating sequences, and telomeres in Saccharomyces cerevisiae. Mol. Cell. Biol. 1988, 8:210-225.
4. Byrne C.D., Olufadi R., Bruce K.D., Cagampang F.R., Ahmed M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin. Sci. 2009, 116:539-564.
5. Capieaux E., Vignais M.L., Sentenac A., Goffeau A. The yeast H+-ATPase gene is controlled by the promoter binding factor TUF. J.Biol. Chem. 1989, 264:7437-7446.
6. Carmen A.A., Milne L., Grunstein M. Acetylation of the yeast histone H4N terminus regulates its binding to heterochromatin protein SIR3. J.Biol. Chem. 2002, 277:4778-4781.
7. Celli G.B., de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 2005, 7:712-718.
8. Chen Y., Yang Y., van Overbeek M., Donigian J.R., Baciu P., de Lange T., Lei M. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 2008, 319:1092-1096.
9. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
10. Costet P., Legendre C., Moré J., Edgar A., Galtier P., Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J.Biol. Chem. 1998, 273:29577-29585.
11. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
12. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19:2100-2110.
13. Djouadi F., Weinheimer C.J., Saffitz J.E., Pitchford C., Bastin J., Gonzalez F.J., Kelly D.P. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice. J.Clin. Invest. 1998, 102:1083-1091.
14. Hebbachi A.M., Knight B.L., Wiggins D., Patel D.D., Gibbons G.F. Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha. J.Biol. Chem. 2008, 283:4866-4876.
15. Hecht A., Laroche T., Strahl-Bolsinger S., Gasser S.M., Grunstein M. Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins: a molecular model for the formation of heterochromatin in yeast. Cell 1995, 80:583-592.
16. Herrera E., Samper E., Martín-Caballero J., Flores J.M., Lee H.W., Blasco M.A. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 1999, 18:2950-2960.
17. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb. Symp. Quant. Biol. 2002, 67:491-498.
18. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
19. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283:1321-1325.
20. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J.Clin. Invest. 1999, 103:1489-1498.
21. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature 2000, 405:421-424.
22. Kidani Y., Bensinger S.J. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol. Rev. 2012, 249:72-83.
23. Kim B.H., Won Y.S., Kim E.Y., Yoon M., Nam K.T., Oh G.T., Kim D.Y. Phenotype of peroxisome proliferator-activated receptor-alpha(PPARalpha)deficient mice on mixed background fed high fat diet. J.Vet. Sci. 2003, 4:239-244.
24. Kim S.H., Beausejour C., Davalos A.R., Kaminker P., Heo S.J., Campisi J. TIN2 mediates functions of TRF2 at human telomeres. J.Biol. Chem. 2004, 279:43799-43804.
25. Kyrion G., Liu K., Liu C., Lustig A.J. RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev. 1993, 7(7A):1146-1159.
26. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., Westphal H. Efficient invivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 1996, 93:5860-5865.
27. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995, 15:3012-3022.
28. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
29. Lefebvre P., Chinetti G., Fruchart J.C., Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J.Clin. Invest. 2006, 116:571-580.
30. Lenaerts A.J., Johnson C.M., Marrieta K.S., Gruppo V., Orme I.M. Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs. Int. J. Antimicrob. Agents 2005, 26:152-158.
31. Leone T.C., Weinheimer C.J., Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 1999, 96:7473-7478.
32. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., Courtois M., Wozniak D.F., Sambandam N., Bernal-Mizrachi C., et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005, 3:e101.
33. Leuenberger N., Pradervand S., Wahli W. Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. J.Clin. Invest. 2009, 119:3138-3148.
34. Li B., de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol. Biol. Cell 2003, 14:5060-5068.
35. Li B., Oestreich S., de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 2000, 101:471-483.
36. Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., Brown M.S. Diminished hepatic response to fasting/refeeding and liver Xreceptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J.Biol. Chem. 2002, 277:9520-9528.
37. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
38. Lowell B.B., S-Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., Kozak L.P., Flier J.S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
39. Marcand S., Gilson E., Shore D. A protein-counting mechanism for telomere length regulation in yeast. Science 1997, 275:986-990.
40. Martin G., Schoonjans K., Lefebvre A.M., Staels B., Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J.Biol. Chem. 1997, 272:28210-28217.
41. Martínez P., Blasco M.A. Role of shelterin in cancer and aging. Aging Cell 2010, 9:653-666.
42. Martínez P., Blasco M.A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 2011, 11:161-176.
43. Martinez P., Thanasoula M., Carlos A.R., Gómez-López G., Tejera A.M., Schoeftner S., Dominguez O., Pisano D.G., Tarsounas M., Blasco M.A. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat. Cell Biol. 2010, 12:768-780.
44. McCall M.N., Uppal K., Jaffee H.A., Zilliox M.J., Irizarry R.A. The Gene Expression Barcode: leveraging public data repositories to begin cataloging the human and murine transcriptomes. Nucleic Acids Res. 2011, 39(Database issue):D1011-D1015.
45. Motojima K., Passilly P., Peters J.M., Gonzalez F.J., Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J.Biol. Chem. 1998, 273:16710-16714.
46. Palm W., de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
47. Rakhshandehroo M., Hooiveld G., Müller M., Kersten S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One 2009, 4:e6796.
48. Rakhshandehroo M., Knoch B., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010, 2010:612089.
49. Rosenbloom K.R., Sloan C.A., Malladi V.S., Dreszer T.R., Learned K., Kirkup V.M., Wong M.C., Maddren M., Fang R., Heitner S.G., et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 2013, 41(Database issue):D56-D63.
50. Sahin E., Colla S., Liesa M., Moslehi J., Müller F.L., Guo M., Cooper M., Kotton D., Fabian A.J., Walkey C., et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-365.
51. Sanderson L.M., Boekschoten M.V., Desvergne B., Müller M., Kersten S. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver. Physiol. Genomics 2010, 41:42-52.
52. Sfeir A., Kabir S., van Overbeek M., Celli G.B., de Lange T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010, 327:1657-1661.
53. Shibayama Y. The role of hepatic venous congestion and endotoxaemia in the production of fulminant hepatic failure secondary to congestive heart failure. J.Pathol. 1987, 151:133-138.
54. Shore D., Nasmyth K. Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elements. Cell 1987, 51:721-732.
55. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 2003, 13:1549-1556.
56. Tanny J.C., Dowd G.J., Huang J., Hilz H., Moazed D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 1999, 99:735-745.
57. Tejera A.M., Stagno d'Alcontres M., Thanasoula M., Marion R.M., Martinez P., Liao C., Flores J.M., Tarsounas M., Blasco M.A. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev. Cell 2010, 18:775-789.
58. Teo H., Ghosh S., Luesch H., Ghosh A., Wong E.T., Malik N., Orth A., de Jesus P., Perry A.S., Oliver J.D., et al. Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat. Cell Biol. 2010, 12:758-767.
59. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413.
60. Yang X., Figueiredo L.M., Espinal A., Okubo E., Li B. RAP1 is essential for silencing telomeric variant surface glycoprotein genes in Trypanosoma brucei. Cell 2009, 137:99-109.
61. Ye J.Z., Hockemeyer D., Krutchinsky A.N., Loayza D., Hooper S.M., Chait B.T., de Lange T. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 2004, 18:1649-1654.
62. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.